Sale!

AMER1 Gene Osteopathia Striata with Cranial Sclerosis Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “AMER1 Gene Osteopathia Striata with Cranial Sclerosis Genetic Test” is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the AMER1 gene. This gene plays a crucial role in bone development and density, and mutations can lead to osteopathia striata with cranial sclerosis (OSCS), a rare genetic disorder characterized by striations in the bones, particularly in the pelvis and long bones, along with sclerosis (hardening) of the cranial bones. The condition may also present with other physical anomalies and developmental challenges.

The test, priced at 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the AMER1 gene. This precise genetic testing is vital for early diagnosis, allowing for appropriate management and treatment plans to be established for individuals affected by OSCS. Moreover, it can provide essential information for family planning and genetic counseling for families with a history of this disorder. DNA Labs UAE ensures confidentiality and accuracy in the testing process, offering a crucial resource for individuals and families dealing with OSCS.

Description

AMER1 Gene Osteopathia striata with cranial sclerosis Genetic Test

Test Name: AMER1 Gene Osteopathia striata with cranial sclerosis Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for AMER1 Gene Osteopathia striata with cranial sclerosis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AMER1 Gene Osteopathia striata with cranial sclerosis NGS Genetic DNA Test gene AMER1

Test Details: The AMER1 gene is associated with a rare genetic disorder called Osteopathia striata with cranial sclerosis (OSCS). This disorder primarily affects the skeletal system, causing abnormal bone growth and density, particularly in the long bones of the limbs and the skull. Individuals with OSCS may also have distinctive facial features and dental abnormalities. NGS (Next-Generation Sequencing) genetic testing is a type of DNA sequencing technology that can analyze multiple genes simultaneously. It is commonly used to identify genetic mutations or variations associated with various disorders, including OSCS. NGS testing can provide a comprehensive analysis of the AMER1 gene, allowing healthcare professionals to detect any mutations or variations that may be contributing to the development of OSCS. By identifying specific genetic changes in the AMER1 gene, NGS genetic testing can help confirm a diagnosis of OSCS and provide valuable information for managing the condition. It can also be used for genetic counseling and family planning purposes. It is important to note that genetic testing should be performed and interpreted by healthcare professionals who specialize in genetics or genetic counseling. They can provide guidance on the implications of test results and help individuals and families understand the potential risks and treatment options associated with OSCS.

Test Name	AMER1 Gene Osteopathia striata with cranial sclerosis Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for AMER1 Gene Osteopathia striata with cranial sclerosis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AMER1 Gene Osteopathia striata with cranial sclerosis NGS Genetic DNA Test gene AMER1
Test Details	The AMER1 gene is associated with a rare genetic disorder called Osteopathia striata with cranial sclerosis (OSCS). This disorder primarily affects the skeletal system, causing abnormal bone growth and density, particularly in the long bones of the limbs and the skull. Individuals with OSCS may also have distinctive facial features and dental abnormalities. NGS (Next-Generation Sequencing) genetic testing is a type of DNA sequencing technology that can analyze multiple genes simultaneously. It is commonly used to identify genetic mutations or variations associated with various disorders, including OSCS. NGS testing can provide a comprehensive analysis of the AMER1 gene, allowing healthcare professionals to detect any mutations or variations that may be contributing to the development of OSCS. By identifying specific genetic changes in the AMER1 gene, NGS genetic testing can help confirm a diagnosis of OSCS and provide valuable information for managing the condition. It can also be used for genetic counseling and family planning purposes. It is important to note that genetic testing should be performed and interpreted by healthcare professionals who specialize in genetics or genetic counseling. They can provide guidance on the implications of test results and help individuals and families understand the potential risks and treatment options associated with OSCS.